Loading: 100%
Natus Medical Inc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 1,160 (as per Q2 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker BABYno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 173034384246
datesClosing price (adj.)
13.10.201740.10
11.10.201740.30
04.10.201739.70
27.09.201737.10
20.09.201734.30
13.09.201735.40
06.09.201733.80
30.08.201732.95
23.08.201732.20
16.08.201734.15
09.08.201733.75
02.08.201735.15
26.07.201736.25
19.07.201738.65
12.07.201737.40
05.07.201737.75
27.06.201735.95
20.06.201735.60
13.06.201735.45
06.06.201734.80
30.05.201734.20
23.05.201733.75
16.05.201734.10
09.05.201734.30
02.05.201735.55
25.04.201740.40
18.04.201739.40
11.04.201739.15
04.04.201738.70
28.03.201738.70
21.03.201738.45
14.03.201737.10
07.03.201737.25
28.02.201737.03
21.02.201737.90
14.02.201736.30
07.02.201735.35
31.01.201739.05
24.01.201738.70
17.01.201738.50
10.01.201736.55
03.01.201735.10
27.12.201634.95
19.12.201634.80
12.12.201638.85
05.12.201637.05
28.11.201642.00
21.11.201643.50
14.11.201641.00
07.11.201639.45
31.10.201639.35
24.10.201641.30
17.10.201640.15
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
40.10n/a
Market Capitalisation
in million USD
1,329n/a
Enterprise Value
in million USD
1,358n/a
Common Shares Outstanding
as per Jul 31, 2017
33,149,616n/a
Preferred Shares Outstanding
as per Jul 31, 2017
n/a
Average Basic Shares Outstanding
TTM
32,452,500n/a
Average Diluted Shares Outstanding
TTM
32,758,250n/a
Index Membership
n/a
Business Summary
Natus Medical Inc provides newborn care & neurology healthcare products & services used for screening, diagnosis, detection, treatment, monitoring & tracking of medical ailments in newborn care, epilepsy, sleep disorders, and balance & mobility disorders.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 445n/a
Gross Profit 256n/a
Operating Income 26n/a
EBITDA 49n/a
Net Profit 19n/a
Balance Sheet
Cash and Cash Equivalents 80n/a
Receivables 114n/a
Total Current Assets 287n/a
PP&E 21n/a
Total Assets 663n/a
Accounts Payable 27n/a
Current Debt 0n/a
Total Current Liabilities 86n/a
Long-Term Debt 109n/a
Total Liabilities 236n/a
Total Equity 426n/a
Cash Flow
Depreciation & Amortisation 22n/a
Change in Working Capital -14n/a
Operating Cash Flow 50n/a
Net Change in PP&E and Intangibles -3n/a
Investing Cash Flow -20n/a
Dividends Paid 0n/a
Financing Cash Flow -49n/a
Total Change in Cash -16n/a
Free Cash Flow 28n/a
Profitability Ratios
Gross Margin 57.5%n/a
Operating Margin 5.9%n/a
Net Profit Margin 4.2%n/a
Return on Equity 4.4%n/a
Return on Assets 2.9%n/a
Per Share Figures
Basic EPS 0.58n/a
Diluted EPS 0.58n/a
Sales per Share 13.73n/a
Book Value per Share 13.14n/a
FCF per Share 0.86n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 69.01n/a
Price to Sales Ratio 2.92n/a
Price to Book Value 3.05n/a
Price to Free Cash Flow 46.45n/a
Valuation Metrics
EV/EBITDA 27.98n/a
EV/Sales 3.05n/a
Book to Market Value 0.32n/a
Other Ratios
Current Ratio 332.8%n/a
Liabilities to Equity Ratio 55.4%n/a
Debt to Assets Ratio 16.5%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
166
218
233
292
344
356
376
382
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-66
-89
-102
-129
-142
-141
-148
-147
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
100
130
131
163
202
214
228
235
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-85
-112
-122
-158
-163
-164
-172
-178
Selling, General & Administrative
-68
-91
-96
-128
-127
-131
-134
-136
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-17
-21
-26
-30
-31
-30
-30
-33
Depreciation & Amortization
0
0
0
0
-6
-3
-7
-9
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
15
18
10
5
39
50
56
57
Non-Operating Income (Loss)
2
0
0
-1
-3
0
-1
0
Interest Expense, net
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
2
0
0
-1
-3
0
-1
0
Pretax Income (Loss), Adjusted
17
18
10
4
37
50
55
56
Abnormal Gains (Losses)
0
0
-20
0
-5
-4
-2
-2
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
17
18
-10
4
32
46
52
55
Income Tax (Expense) Benefit, net
-6
-6
-1
0
-9
-14
-14
-12
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
11
12
-11
4
23
32
38
43
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
11
12
-11
4
23
32
38
43
Minority Interest
0
0
0
0
0
0
0
0
Net Income
11
12
-11
4
23
32
38
43
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
11
12
-11
4
23
32
38
43
Remarks
restated on Mar 14, 2012 n/a
calculated values,
restated on Apr 10, 2013 n/a
calculated values,
restated on Mar 17, 2014 n/a
calculated values,
restated on Mar 16, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 24, 2017 n/a
calculated values,
restated on Feb 24, 2017 n/a
calculated values,
restated on Feb 24, 2017 n/a
calculated values,
Balance SheetBS data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
29
33
23
56
67
82
248
Cash & Cash Equivalents
n/a
28
33
23
56
67
82
214
Short Term Investments
n/a
1
0
0
0
0
0
34
Accounts & Notes Receivable
n/a
55
55
90
82
82
99
87
Accounts Receivable, Net
n/a
55
55
90
82
82
99
87
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
38
33
41
41
40
49
50
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
7
10
15
21
29
11
22
Prepaid Expenses
n/a
5
5
6
12
17
11
22
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
2
5
9
9
12
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
Total Current Assets
n/a
129
131
169
200
218
241
406
Property, Plant & Equipment, Net
n/a
23
26
27
23
18
17
17
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
179
158
196
206
199
221
226
Intangible Assets
n/a
69
70
97
99
93
87
77
Goodwill
n/a
97
80
92
97
96
107
113
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
1
13
15
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
12
7
8
10
9
14
21
Total Noncurrent Assets
n/a
202
184
223
230
217
238
243
Total Assets
n/a
331
315
392
429
435
479
649
Liabilities and owners' equity
Payables & Accruals
n/a
39 39311000
34 33526000
65 65475000
58 57731000
57 57395000
66 65797000
57 56595000
Accounts Payable
n/a
22 21684000
16 16404000
33 32537000
30 29777000
21 21371000
24 23660000
19 18700000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
18 17627000
17 17122000
33 32938000
28 27954000
36 36024000
42 42137000
38 37895000
Short Term Debt
n/a
0 156000
0 188000
20 19826000
11 10517000
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
5 4744000
8 7604000
13 13305000
13 12946000
12 11745000
11 11311000
23 23346000
Deferred Revenue
n/a
5 4744000
8 7604000
13 13305000
13 12946000
12 11745000
11 11311000
23 23346000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
44 44211000
41 41318000
99 98606000
81 81194000
69 69140000
77 77108000
80 79941000
Long Term Debt
n/a
1 737000
1 710000
13 13034000
28 27500000
0 0
0 0
140 140000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
22 22034000
15 14505000
11 11461000
13 12549000
13 12966000
12 11678000
12 11697000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
14 13958000
8 8490000
8 8423000
10 9704000
8 8107000
4 3897000
4 3684000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
8 8076000
6 6015000
3 3038000
3 2845000
5 4859000
8 7781000
8 8013000
Total Noncurrent Liabilities
n/a
23 22771000
15 15215000
24 24495000
40 40049000
13 12966000
12 11678000
152 151697000
Total Liabilities
n/a
67 66982000
57 56533000
123 123101000
121 121243000
82 82106000
89 88786000
232 231638000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
259 258872000
267 267499000
275 275395000
292 292055000
315 315296000
324 323745000
313 312986000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
19 18867000
8 7755000
12 11638000
36 36412000
69 68890000
107 106814000
149 149408000
Other Equity
n/a
-14 -13674000
-17 -16941000
18 18281000
-20 -20253000
-31 -31471000
-40 -39849000
-45 -45020000
Equity Before Minority Interest
n/a
264 264065000
258 258313000
305 305314000
308 308214000
353 352715000
391 390710000
417 417374000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
264 264065000
258 258313000
305 305314000
308 308214000
353 352715000
391 390710000
417 417374000
Total Liabilities & Equity
n/a
331 331047000
315 314846000
428 428415000
429 429457000
435 434821000
479 479496000
649 649012000
Remarks restated on n/a restated on Mar 14, 2012 n/a restated on Apr 10, 2013 n/a restated on Mar 17, 2014 n/a restated on Mar 16, 2015 n/a restated on Feb 29, 2016 n/a restated on Feb 24, 2017 n/a restated on Aug 7, 2017 n/a
Cash Flow StatementCF data quality: 93% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
11
12
-11
4
23
32
38
43
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
8
9
10
13
13
12
16
17
Non-Cash Items
6
7
35
11
7
5
12
13
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
2
-16
-10
-8
-6
-7
-29
0
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
27
11
24
19
37
42
37
73
Change in Fixed Assets & Intangibles
-4
-4
-5
-7
-4
-6
-5
-3
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-47
-13
-15
-55
-19
-5
-14
-16
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
-1
0
1
25
35
0
0
106
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-52
-18
-19
-37
13
-11
-19
87
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
-1
0
7
-30
-38
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
1
3
2
2
9
12
-1
-16
Increase in Capital Stock
1
3
2
2
9
16
10
4
Decrease in Capital Stock
0
0
0
0
0
-5
-12
-19
Other Financing Activities
-1
1
2
0
3
6
2
-6
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
0
2
4
8
-18
-21
1
-22
Net Cash Before Disc. Operations and FX
-25
-5
8
-10
32
11
18
138
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
-25
-5
8
-10
32
11
18
138
Effect of Foreign Exchange Rates
0
1
-1
0
1
0
-2
-7
Net Changes in Cash
-24
-4
7
-10
33
10
16
131
Remarks
restated on Mar 14, 2012 n/a
calculated values,
restated on Apr 10, 2013 n/a
calculated values,
restated on Mar 17, 2014 n/a
calculated values,
restated on Mar 16, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 24, 2017 n/a
calculated values,
restated on Feb 24, 2017 n/a
calculated values,
restated on Feb 24, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo